Inclusion Criteria:
  1. Have been enrolled in the OPP-002 study
  2. Have received at least one dose of the study drug/placebo in OPP-002 study
  3. Completed the OPP-002 study to Visit 5
  4. Have provided verbal and written informed consent
Exclusion Criteria:
1. Have discontinued prior to Visit 5 in the OPP-002 study.